CEBRX
Price
$9.82
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
293.48M
MEDCX
Price
$12.36
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
7.43B
Interact to see
Advertisement

CEBRX vs MEDCX

Header iconCEBRX vs MEDCX Comparison
Open Charts CEBRX vs MEDCXBanner chart's image
Columbia Emerging Markets Bond Inst2
Price$9.82
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets293.48M
MFS Emerging Markets Debt C
Price$12.36
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets7.43B
CEBRX vs MEDCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CEBRX vs. MEDCX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEBRX is a Hold and MEDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDCX has more cash in the bank: 7.43B vs. CEBRX (293M). CEBRX pays higher dividends than MEDCX: CEBRX (5.40) vs MEDCX (4.89). CEBRX was incepted earlier than MEDCX: CEBRX (13 years) vs MEDCX (23 years). MEDCX (1.82) is less costly to investors than CEBRX (0.75). MEDCX is a more actively managed with annual turnover of: 58.00 vs. CEBRX (41.00). CEBRX has a lower initial minimum investment than MEDCX: CEBRX (0) vs MEDCX (1000). CEBRX annual gain was more profitable for investors over the last year : 9.77 vs. MEDCX (7.88). CEBRX return over 5 years is better than : 8.80 vs. MEDCX (4.36).
CEBRXMEDCXCEBRX / MEDCX
Total Expense Ratio0.751.8141%
Annual Report Gross Expense Ratio0.751.8241%
Fund Existence13 years23 years-
Gain YTD7.0445.680124%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets293M7.43B4%
Annual Yield % from dividends5.404.89110%
Returns for 1 year9.777.88124%
Returns for 3 years25.5523.06111%
Returns for 5 years8.804.36202%
Returns for 10 years44.6730.55146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUSX17.430.13
+0.75%
Lazard US Equity Focus Instl
PRDGX82.16N/A
N/A
T. Rowe Price Dividend Growth
GSCKX16.77N/A
N/A
Goldman Sachs International Eq Inc C
SSLCX51.53N/A
N/A
DWS Small Cap Core S
LINTX22.54N/A
N/A
Lord Abbett International Opp R5